scispace - formally typeset
S

Si-Xue Cheng

Researcher at Wuhan University

Publications -  238
Citations -  12634

Si-Xue Cheng is an academic researcher from Wuhan University. The author has contributed to research in topics: Drug carrier & Micelle. The author has an hindex of 54, co-authored 236 publications receiving 10754 citations. Previous affiliations of Si-Xue Cheng include Sichuan University & University of South China.

Papers
More filters
Journal ArticleDOI

Thermo-sensitive polymeric micelles based on poly(N-isopropylacrylamide) as drug carriers

TL;DR: In this article, the authors present a review of the recent developments in this field, and focus on two categories of PNIPAAm-based copolymer micelles as smart drug delivery systems.
Journal ArticleDOI

Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery.

TL;DR: A novel type of cellular-uptake-shielding multifunctional envelope-type mesoporous silica nanoparticle designed for tumor-triggered targeting drug delivery to cancerous cells was designed and in vitro study demonstrated that MEMSN was shielded against normal cells.
Journal ArticleDOI

Drug self-delivery systems for cancer therapy

TL;DR: This review presents a comprehensive summary of the recent advances in carrier-assistant drug delivery systems for cancer therapy and emphatically discusses some representative achievements of these DSDSs for passive or/and positive targeting therapy, combinational therapy as well as theranostics.
Journal ArticleDOI

Switching Apoptosis to Ferroptosis: Metal–Organic Network for High-Efficiency Anticancer Therapy

TL;DR: MON encapsulated with p53 plasmid (MON-p53) was designed to eradicate cancer cells via ferroptosis/apoptosis hybrid pathway by harnessing the recently discovered oxidative stress regulation ability of p53 and the Fenton reaction inducing capability of metal-organic network.
Journal ArticleDOI

Functionalized amphiphilic hyperbranched polymers for targeted drug delivery.

TL;DR: The results showed the drug-loaded nanoparticles exhibited enhanced cell inhibition because folate targeting increased the cytotoxicity of drug- loaded nanoparticles against folate receptor expressing tumor cells.